グリーンランドの代謝性疾患治療に影響を与える大規模遺伝子マッピング (Extensive Genetic Mapping Could Significantly Impact the Treatment of Metabolic Diseases in Greenland)

ad

2025-03-14 コペンハーゲン大学 (UCPH)

コペンハーゲン大学の研究者は、グリーンランドの6,000人を対象に大規模な遺伝子解析を実施し、代謝性疾患の診断や治療の改善につながる重要な知見を得た。研究では、グリーンランド人の遺伝的変異は少ないが、特定の疾患リスクが高いことが判明。例えば、糖尿病リスクが高い人が約5%、スクロース不耐症の有病率が約4%に達し、ヨーロッパの約5万人に1人と比べ大幅に高い。この研究は、グリーンランドの遺伝的背景をより深く理解し、個別化医療の発展に貢献する可能性がある。

<関連情報>

グリーンランドの遺伝的構造は人口動態、構造、淘汰によって形成される Genetic architecture in Greenland is shaped by demography, structure and selection

Frederik Filip Stæger,Mette K. Andersen,Zilong Li,Jasmin Pernille Hjerresen,Shixu He,Cindy G. Santander,Rasmus Tanderup Jensen,Karsten Fleischer Rex,Anne Cathrine Baun Thuesen,Kristian Hanghøj,Inge Høst Seiding,Emil Jørsboe,Sara Elizabeth Stinson,Malthe Sebro Rasmussen,Renzo F. Balboa,Christina Viskum Lytken Larsen,Peter Bjerregaard,Mikkel Schubert,Jonas Meisner,Allan Linneberg,Niels Grarup,Eleftheria Zeggini,Rasmus Nielsen,Marit E. Jørgensen,… Anders Albrechtsen
Nature  Published:12 February 2025
DOI:https://doi.org/10.1038/s41586-024-08516-4

グリーンランドの代謝性疾患治療に影響を与える大規模遺伝子マッピング (Extensive Genetic Mapping Could Significantly Impact the Treatment of Metabolic Diseases in Greenland)

Abstract

Greenlandic Inuit and other indigenous populations are underrepresented in genetic research, leading to inequity in healthcare opportunities. To address this, we performed analyses of sequenced or imputed genomes of 5,996 Greenlanders with extensive phenotypes. We quantified their historical population bottleneck and how it has shaped their genetic architecture to have fewer, but more common, variable sites. Consequently, we find twice as many high-impact genome-wide associations to metabolic traits in Greenland compared with Europe. We infer that the high-impact variants arose after the population split from Native Americans and thus are Arctic-specific, and show that some of them are common due to not only genetic drift but also selection. We also find that European-derived polygenic scores for metabolic traits are only half as accurate in Greenlanders as in Europeans, and that adding Arctic-specific variants improves the overall accuracy to the same level as in Europeans. Similarly, lack of representation in public genetic databases makes genetic clinical screening harder in Greenlandic Inuit, but inclusion of Greenlandic data remedies this by reducing the number of non-causal candidate variants by sixfold. Finally, we identify pronounced genetic fine structure that explains differences in prevalence of monogenic diseases in Greenland and, together with recent changes in mobility, leads to a predicted future reduction in risk for certain recessive diseases. These results illustrate how including data from Greenlanders can greatly reduce inequity in genomic-based healthcare.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました